GLI3 and neoplasm: Since GLI-3 over-expression reduced tumor cell proliferation and induced apoptosis in colon CSCs [55], the GLI-3 induction by Bozepinib could be one of the mechanisms by which this drug exerts its anti-tumor activity in colon CSCs that must be deeply explored.